ArticleThe Eurasian journal of medicine2026
Investigation of CLOCK rs1801260 Polymorphism of Circadian Genes in Schizophrenia Patients.
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSchizophrenia is a mental condition characterized by abnormalities in emotional reactivity, thought processes, and perception. Recent studies have suggested a possible connection between the pathophysiology of schizophrenia and the CLOCK gene, a key element of the biological circadian rhythm. The CLOCK rs1801260 polymorphism has not yet been studied in a Turkish population with schizophrenia, and the existing data are contradictory. This study aimed to compare and interpret the CLOCK rs1801260 polymorphism in terms of demographic characteristics, genotype, and allele distribution in patients with schizophrenia and healthy controls.
methodsDeoxyribonucleic acid was purified from peripheral blood samples of 50 schizophrenia patients and 50 healthy control subjects, matched for age and sex. Genotyping was conducted by real-time polymerase chain reaction using the TaqMan Kit.
resultsThe odds of having the risk-associated TC or CC genotypes vs. the TT genotype were significantly higher in patients with schizophrenia compared to healthy controls (odds ratio (OR) = 2.92), and the risk C allele was also twice as prevalent in schizophrenia patients (OR = 2.00). The distributions of CLOCK rs1801260 genotypes (TT, TC, and CC) in the schizophrenia and the healthy control groups were independent of age and sex.
conclusionThe presence of the TC or CC genotypes, or having the homozygous or heterozygous C allele, may pose a risk for schizophrenia in the Turkish population. If confirmed in larger and more diverse samples, the CLOCK rs1801260 polymorphism may serve as a genetic marker for identifying at-risk individuals and guiding individualized treatment strategies aimed at stabilizing circadian rhythm. Cite this article as: Yekayeva P, Türkgenç B, Gözler T, Yüksel I, Ulucan K, Tarhan N. Investigation of CLOCK rs1801260 polymorphism of circadian genes in schizophrenia patients. Eurasian J Med. 2026, 58(4), 1049, doi: 10.5152/eurasianjmed.2026.251049.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.